Neutrons Settle 40-Year Debate on Enzyme for Cancer Drug Design

Credit: Sumner Brown Gibbs/ORNL, U.S. Dept. of Energy

ORNL scientists Victoria Drago and Andrey Kovalevsky used the MaNDi instrument at the Spallation Neutron Source to discover new details of an enzyme that can aid cancer drug design.

« Neutrons Settle 40-Year Debate on Enzyme for Cancer Drug Design

Credit: Sumner Brown Gibbs/ORNL, U.S. Dept. of Energy

Drago and Kovalevsky examine the crystal Drago grew at ORNL to learn more about chemical reactions for SHMT, an enzyme that falls early in the one-carbon metabolic pathway.

« Neutrons Settle 40-Year Debate on Enzyme for Cancer Drug Design

Expert Pitch

Expert Query

Expert Directory